Nr CAM is a marker for substrate‐selective activation of ADAM 10 in Alzheimer's disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Nr CAM is a marker for substrate‐selective activation of ADAM 10 in Alzheimer's disease ; volume:11 ; number:4 ; year:2019 ; extent:20
EMBO molecular medicine / European Molecular Biology Organization ; 11, Heft 4 (2019) (gesamt 20)

Creator: Brummer, Tobias
Müller, Stephan A.
Pan‐Montojo, Francisco
Yoshida, Fumiaki
Fellgiebel, Andreas
Tomita, Taisuke
Endres, Kristina
Lichtenthaler, Stefan

DOI: 10.15252/emmm.201809695

URN: urn:nbn:de:101:1-2022081208474257889334

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:37 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Brummer, Tobias
Müller, Stephan A.
Pan‐Montojo, Francisco
Yoshida, Fumiaki
Fellgiebel, Andreas
Tomita, Taisuke
Endres, Kristina
Lichtenthaler, Stefan

Other Objects (12)

Highly Substrate‐Selective Macrocyclic Ring Closing Metathesis

Konferenzschrift | Kongress

Biological markers of Alzheimer's disease

Substrate Rigidity Effect on CAD/CAM Restorations at Different Thicknesses

Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach

Unmasking selective path integration deficits in Alzheimer’s disease risk carriers

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations

Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate

CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Evaluating frontoparietal network topography for diagnostic markers of Alzheimer’s disease

Memory markers in the continuum of the Alzheimer’s clinical syndrome

Hochschulschrift

Development of selective fluorescent imaging agents for neurofibrillary tangles in Alzheimer’s diagnosis

Highly Substrate‐Selective Macrocyclic Ring Closing Metathesis

Konferenzschrift | Kongress

Biological markers of Alzheimer's disease

Substrate Rigidity Effect on CAD/CAM Restorations at Different Thicknesses

Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach

Unmasking selective path integration deficits in Alzheimer’s disease risk carriers

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations

Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate

CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Evaluating frontoparietal network topography for diagnostic markers of Alzheimer’s disease

Memory markers in the continuum of the Alzheimer’s clinical syndrome

Hochschulschrift

Development of selective fluorescent imaging agents for neurofibrillary tangles in Alzheimer’s diagnosis

Highly Substrate‐Selective Macrocyclic Ring Closing Metathesis

Konferenzschrift | Kongress

Biological markers of Alzheimer's disease

Substrate Rigidity Effect on CAD/CAM Restorations at Different Thicknesses

Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach

Unmasking selective path integration deficits in Alzheimer’s disease risk carriers

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations

Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate

CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Evaluating frontoparietal network topography for diagnostic markers of Alzheimer’s disease

Memory markers in the continuum of the Alzheimer’s clinical syndrome

Hochschulschrift

Development of selective fluorescent imaging agents for neurofibrillary tangles in Alzheimer’s diagnosis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Nr CAM is a marker for substrate‐selective activation of ADAM 10 in Alzheimer's disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Highly Substrate‐Selective Macrocyclic Ring Closing Metathesis

Biological markers of Alzheimer's disease

Substrate Rigidity Effect on CAD/CAM Restorations at Different Thicknesses

Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach

Unmasking selective path integration deficits in Alzheimer’s disease risk carriers

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations

Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate

CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Evaluating frontoparietal network topography for diagnostic markers of Alzheimer’s disease

Memory markers in the continuum of the Alzheimer’s clinical syndrome

Development of selective fluorescent imaging agents for neurofibrillary tangles in Alzheimer’s diagnosis

Highly Substrate‐Selective Macrocyclic Ring Closing Metathesis

Biological markers of Alzheimer's disease

Substrate Rigidity Effect on CAD/CAM Restorations at Different Thicknesses

Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach

Unmasking selective path integration deficits in Alzheimer’s disease risk carriers

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations

Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate

CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Evaluating frontoparietal network topography for diagnostic markers of Alzheimer’s disease

Memory markers in the continuum of the Alzheimer’s clinical syndrome

Development of selective fluorescent imaging agents for neurofibrillary tangles in Alzheimer’s diagnosis

Highly Substrate‐Selective Macrocyclic Ring Closing Metathesis

Biological markers of Alzheimer's disease

Substrate Rigidity Effect on CAD/CAM Restorations at Different Thicknesses

Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach

Unmasking selective path integration deficits in Alzheimer’s disease risk carriers

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations

Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate

CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Evaluating frontoparietal network topography for diagnostic markers of Alzheimer’s disease

Memory markers in the continuum of the Alzheimer’s clinical syndrome

Development of selective fluorescent imaging agents for neurofibrillary tangles in Alzheimer’s diagnosis

Related objects

Reset password